/
Pharmaceutical preparations company · E9 · FY ends Mar · Revenue $86M · -14.03% margin · -$19M FCF
The business is unprofitable at the operating level (-14.03% margin). The thesis depends entirely on whether and when it reaches sustainable profitability.
Revenue grew 6.0%, steady but not accelerating.
Negative free cash flow of -$19M. The business is consuming cash, not generating it.
Profitability & Returns
Revenue (TTM)
$86M
▲ +6.0% YoY
Net Income (TTM)
-$14M
▲ +77.2% YoY
Op. Margin
-14.03%
▲ +63.7pp YoY
ROIC
-7.04%
▲ +23.9pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
-$19M
▲ +61.1% YoY
Op. Cash Flow (TTM)
-$17M
▲ +59.5% YoY
Net Debt
$43M
Cash & Equiv.
$15M
Continue Research